IL1B and inflammation: In our study, YCF treatment significantly inhibited pulmonary inflammation in silica-exposed rats, by reducing inflammatory cell infiltration, and decreasing the secretion of inflammatory chemokines, including TNF-α, IL-1β, and IL-6.